State of the Art Medical Management of Nasal Polyps
American Journal of Rhinology & Allergy · 2023-03 · 37 (2) · 153-161
DOI: 10.1177/19458924221145256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Rhinology & Allergy, online erschienen am 27.02.2023. Verfasst von Kelly L Staricha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Nasal Polyps, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory disease with a treatment goal of controlling symptoms and limiting disease burden. While endoscopic sinus surgery is effective for removing polyps and aerating sinuses, proper medical management remains necessary for reducing inflammation and limiting polyp recurrence.
Objective
This article aims to summarize the literature regarding medical treatment of chronic rhinosinusitis with nasal polyposis, with a specific focus on developments in the past 5 years. Methodology We conducted a literature review using PubMed to identify studies assessing medical treatment strategies for patients with CRSwNP. Articles focusing on chronic rhinosinusitis without nasal polyposis were excluded unless specifically stated. Surgical treatment and biologic therapies for CRSwNP will be covered in subsequent chapters and are therefore not included.
Results
Intranasal saline irrigations and topical steroids are mainstays of CRSwNP treatment in the pre-surgical, post-surgical, and maintenance phases of the disease. Alternative steroid delivery methods and adjunctive treatments with antibiotics, anti-leukotrienes, and other topical therapies have been investigated and may benefit certain patient populations, but convincing evidence does not exist to warrant addition of these treatments to the standard of care for CRSwNP.
Conclusions
Topical steroid therapy is clearly effective for CRSwNP, and recent studies demonstrate the safety and efficacy of high-dose nasal steroid rinses. Alternate delivery methods for local steroids may be useful for patients who are not responding to or who are noncompliant with conventional intranasal corticosteroid sprays and rinses. Future studies are needed to clarify if oral or topical antibiotics, oral anti-leukotrienes, or other novel therapies are significantly effective in decreasing symptoms and improving the quality of life in patients with CRSwNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Janalee K Stokken
Zitieren
APA
Staricha, K. L., Ali, H. M., & Stokken, J. K. (2023). State of the Art Medical Management of Nasal Polyps. American Journal of Rhinology & Allergy, 37(2), 153-161. https://doi.org/10.1177/19458924221145256
Vancouver
Staricha KL, Ali HM, Stokken JK. State of the Art Medical Management of Nasal Polyps. American Journal of Rhinology & Allergy. 2023;37(2):153-161. doi:10.1177/19458924221145256
BibTeX
@article{Staricha2023,
author = {Staricha, Kelly L and Ali, Hawa M and Stokken, Janalee K},
title = {State of the Art Medical Management of Nasal Polyps},
journal = {American Journal of Rhinology & Allergy},
year = {2023},
volume = {37},
number = {2},
pages = {153--161},
doi = {10.1177/19458924221145256}
}
EUVIMED